[Tamoxifen therapy in previously treated female patients].
We did a pilot study in 35 pretreated cases with disseminated metastatic breast cancer. These patients got a therapy of about 20 mg/day. We evaluated objective remissions, but also subjective responses. In good correlation to similar trials we found benefits in 35%.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D013629:Tamoxifen
Mitteilung über Tamoxifen-Therapie bei vorbehandelten Patientinnen.